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Abstract
Rationale Dopamine (DA) plays an important role in
working memory. However, the precise functions supported
by different DA receptor subtypes in different neural
regions remain unclear.
Objective The present study used pharmacological, event-
related fMRI to test the hypothesis that striatal dopamine is
important for the manipulation of information in working
memory.
Methods Twenty healthy human subjects were scanned
twice, once after placebo and once after sulpiride 400 mg, a
selective DA D2 receptor antagonist, while performing a
verbal working memory task requiring different levels of
manipulation.
Results Whilst there was no overall effect of sulpiride on
task-dependent activation, individual variation in sulpiride
plasma levels predicted the effect of working memory
manipulation on activation in the putamen, suggesting a
dose-dependent effect of DA antagonism on a striatally
based manipulation process. These effects occurred in the
context of a drug-induced improvement in performance on
trials requiring the manipulation of information in working
memory but not on simple retrieval trials. No significant
drug effects were observed in the prefrontal cortex.
Conclusions These results support models of dopamine
function that posit a ‘gating’ function for dopamine D2
receptors in the striatum, which enables the flexible





It is well established that dopamine (DA) D1 receptors in
the prefrontal cortex (PFC) are critical for the maintenance
of task-relevant information in working memory. Perfor-
mance of monkeys on delayed response tasks is impaired
after DA depletion (Brozoski et al. 1979) and is specifically
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DA in the striatum also plays an important role in
working memory. In Parkinson’s disease (PD), progressive
loss of DA neurons in the striatum leads to a profile of
cognitive deficits that is qualitatively similar to that of
patientswithfrontallobedamage,whichincludesimpairments
in working memory and attentional flexibility (Owen 2004).
However, the precise cognitive function supported by striatal
DA remains uncertain.
Converging evidence from monkeys and humans sug-
gests that DA exerts differential effects on cognition in the
PFC and striatum. Crofts et al. (2001) found differential
effects of striatal and prefrontal DA depletion on the
acquisition of an attentional set in monkeys, with depletion
of DA in the PFC leading to increased distractibility and
depletion of DA in the striatum leading to more rigid
responding. Dodds et al. (2008) investigated the effects of
methylphenidate, a non-specific DA agonist, on activation
during reversal learning in healthy human subjects and
found that methylphenidate modulated striatal activation
when subjects switched their response following negative
feedback but prefrontal activation when subjects did not
reverse following negative feedback. These studies suggest
that striatal DA enables flexible responding while prefrontal
DA enables the rigid or focused maintenance of responding.
There is also some evidence to suggest that working
memory deficits associated with striatal DA loss in PD are
subtly different from the deficits observed after DA depletion
intheprefrontalcortex.PatientswithPDareunimpairedwhen
a working memory task requires the maintenance and
subsequent retrieval of spatial information but are impaired
on a task requiring active manipulation of that information
(Owen et al. 1992; Lewis et al. 2003), suggesting that
working memory deficits after striatal DA depletion are more
severe in conditions requiring the updating and flexible
manipulation of information held in working memory.
It has been hypothesised that regionally specific effects of
DA reflect different functional roles for different DA receptor
subtypes in working memory. Specifically, D1 receptor
signalling in the PFC supports the stable maintenance of
working memory representations, while D2 receptor signalling
in the striatum acts as a ‘gating’ mechanism, facilitating or
preventing the access of new working memory representations
into the PFC (Braver et al. 1999; Frank et al. 2001). This
hypothesis receives support from a recent functional neuro-
imaging study by Cools et al. (2007) who found that
bromocriptine, a selective DA D2 agonist, modulated striatal
activation during switching but lateral prefrontal activation
during distraction in high-impulsive subjects.
Thus, functional neuroimaging evidence suggests that
increasing DA function in the striatum modulates activation
associated with the flexible updating of working memory
representations, and that this process may be dependent on
D2 receptor signalling. However, no study has, as yet,
investigated the effects of selectively reducing DA D2
receptor signalling on event-related activation associated
with different component processes of working memory.
Mehta et al. (2003) used positron emission tomography
(PET) to investigate the effects of sulpiride on striatal
regional cerebral blood flow (rCBF) during a working
memory task and found no effect of the drug on rCBF
associated specifically with working memory. There was,
however, some evidence that sulpiride attenuated rCBF in
the caudate nucleus during a more complex planning task
and that the drug-related changes in rCBF were associated
with modulations of performance.
In the present study, we used event-related fMRI to
investigatetheeffectsofasingledoseofsulpirideonactivation
during a working memory task requiring different levels of
manipulationofinformationin working memory. This taskhas
been shown previously to be sensitive to working memory
deficits in PD (Bublak et al. 2002; Lewis et al. 2003)a n dt o
activate discrete prefrontal and striatal regions during fMRI
in healthy volunteers (Lewis et al. 2004).
Participants were scanned once after placebo and once
after sulpiride 400 mg while performing the working
memory task, in the context of a larger design that also
examined the effects of methylphenidate. We predicted that
sulpiride would selectively affect subjects’ ability to
manipulate information in working memory by modulating
striatal activation specifically related to the process of
manipulation, i.e. in the contrast of manipulation trials–
simple retrieval trials. Furthermore, given that 400 mg of
sulpiride has been shown to lead to only 28% occupancy of
DA D2 receptors in the striatum (Mehta et al. 2008), we
expected that effects of sulpiride on striatal activation
would be sensitive to individual differences in drug
absorption. We therefore predicted that sulpiride plasma
levels would correlate with the magnitude of activation in
the contrast of manipulation–simple retrieval trials.
Method
Participants
Twenty healthy, right-handed volunteers (mean age 22.2,
range 19–33 years; 14 male and six female) took part in the
study. Data from three participants were excluded from the
final analysis due to problems with fMRI data acquisition.
Mean verbal IQ measured with the National Adult Reading
Test value was 121, range 116–126. Participants were
recruited among students and staff of Cambridge University
and Addenbrooke’s Hospital. All participants entered the
study after screening by a research psychiatrist (UM) and
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including alcohol and drug abuse. They were asked to abstain
fromalcoholfor12h,aswellasfromcaffeineandnicotinefor
3 h, before testing. A light breakfast or snack was allowed
before, but not during, testing. All participants were ques-
tioned about compliancewithalcohol and caffeine restrictions
before inclusion into the study. All participants gave written
informed consent prior to testing and received monetary
compensation (£200). The protocol was approved by the
Local Research Ethics Committee Cambridge (LREC No.
03/266) and exempted from clinical trial regulations by
Medicines and Healthcare products Regulatory Agency.
Pharmacological design and procedures
The present study was carried out as part of a larger four-arm
design which also investigated the effects of methylphenidate
and sulpiride-methylphenidate combined. However, for
clarity here we report only the results from the sulpiride vs
placebo analysis.
The minimum time between testing sessions was 3 days.
Single oral doses of sulpiride 400 mg (Dolmatil®, Sanofi-
Synthelabo, Guildford, UK) or placebo (lactose with
microcrystalline cellulose) contained in identical opaque
gelatine capsules were administered 2 h before scanning.
Between dosing and scanning, all volunteers were asked to
spend the waiting time with low arousing activities
(reading, watching TV etc.) in a day room and were
monitored by research nurses. Dose selection was based on
previous, similar studies showing behavioural effects at
similar (and lower) doses using the same drugs in healthy
volunteers (Mehta et al. 1999). The timing of scanning was
performed around the time of maximal plasma level
(Sugnaux et al. 1983; Wagstaff et al. 1994).
Prior to scanning on the first session, participants were
trained on the task to reduce practise effects. If the gap
between sessions was more than a week participants were
re-trained on subsequent sessions.
Immediately before and after scanning, a blood sample
was taken from each participant in order to measure drug
plasma levels. Participants also completed visual analogue
scales (VAS), which probed different aspects of participants’
current subjective experiences, at three time-points: baseline
(prior to dosing), immediately before scanning and immedi-
ately after scanning (see Bond and Lader 1974, for details of
the scales).
Unblinding was performed after the analysis of behav-
ioural data and the first-level analysis of fMRI data.
Sulpiride plasma level analysis
Sulpiride plasma levels were analysed by liquid chroma-
tography/mass spectrometry (Gschwend et al. 2006) using a
Finnigan SSQ-7000 (Finnigan/MAT, Bremen, Germany,
now Thermo Electron Corporation) mass spectrometer
equipped with an electrospray ionisation (ESI)/APCI
interface coupled with a ConstaMetric 4100 MS series
pump, a SCM 1000 Vacuum Membran Degasser, an
autosampler AS 3000, and a model 3200 programmable
wavelength detector (Thermo Separation Products, Riviera
Beach, Florida, USA) in ESI SIM mode by monitoring of
the [M+H]
+ ion of the analytes [m/z 342, 237 for sulpiride
and D3-methylphenidate as an internal standard (ISTD)],
respectively. Plasma samples, quality controls and calibra-
tion standards of each 0.5 ml were processed by solid phase
extraction (Oasis HLB, Waters Corporation, Milford, USA).
Chromatrographic separation was achieved on Ultrasep RP
18E column (150×2 mm, Sepserv, Berlin, Germany). A
linear relationship between concentration and signal intensity
(givenaspeakheightratio analyte/ISTD) wasobtained(linear
regression, 0.998) over detection range of the lower limit of
quantification(LLQ)of30upto1,500ng/mL.Thelowerlimit
of detection was 6 ng/mL, recovery rate of sulpiride was
58%, accuracy and precision were 11% and 6%, respectively,
and within- and between-day coefficients of variation were
below 10%.
Working memory task
On each trial, subjects were presented sequentially with
four consonants which they were required to hold in
memory. The consonants were presented with a 1-s interval
between each letter. After stimulus presentation, subjects
saw a blank screen for between 9 and 14 s which served as
a maintenance period. At the end of the maintenance
period, a cue appeared which instructed subjects either to
retrieve the letters from memory in the same order in which
they were presented (retrieval condition), or to rearrange the
letters into a different order (manipulation condition). In the
manipulation condition subjects could be instructed either
to recall the letters in the following order: third; fourth;
first; second (‘pairs’ condition), or, alternatively in the
following order: first; third; second; fourth (‘middle’
condition). For the retrieval condition, the cue was the
word ‘same’, while for the manipulation condition the cue
was either the word ‘middle’ or ‘pairs’. Following the cue,
a blank screen was presented until subjects indicated that
they had performed either the required manipulation
process or the simple retrieval process. Subjects were
instructed to ensure that they had performed these processes
completely before they pressed the button. When the
subject pressed the button, two letter strings were pre-
sented, one above the other, one of which was the ‘correct’
sequence, and the other an incorrect sequence. Subjects
were required to indicate, by pressing one of two buttons
under their index and middle fingers, which sequence was
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presentation of the choice array through to the second
button press served as a motor control period for the
motoric demands of the first response period. This second
button press triggered a feedback message (1 s) indicating
whether the choice was correct or incorrect. Subjects
performed two blocks of 30 randomised trials of the
working memory task, with an equal number of simple
retrieval and manipulation trials (Fig. 1).
Data acquisition and analysis
Participants were scanned at the Wolfson Brain Imaging
Centre (University of Cambridge, UK) on a 3T Bruker
scanner using a head coil. Functional images were collected
using 21 slices covering the whole brain (slice thickness
4 mm, interslice gap 1 mm, in-plane resolution 1.56×
1.56 mm) with an EPI sequence (TR, 1.6 s; TE 27 ms;
matrix size, 128×128). The first 12 volumes were discarded
to allow for T1-equilibrium effects. Structural and functional
images were collected in the axial oblique plane.
All fMRI data were preprocessed (transformed) using
SPM2 and analysed using SPM5 software (Wellcome
Department of Cognitive Neurology, London). During
preprocessing, all images were corrected for slice timing,
subject motion corrected and geometrically undistorted
using phase maps (Cusack et al. 2003). Using the
mean realigned image, all images were coregistered to
a skull-stripped (using the Brain Extraction Tool, Smith
et al. 2002), high-resolution structural scan (voxel size,
1×1×1 mm) which was acquired on the first scanning
day. Images were then normalised, using affine and
smoothly nonlinear transformations, to an EPI template in
Montreal Neurological Institute (MNI) space. Finally, all
normalised images were spatially smoothed with a 10 mm
full-width, half-maximum Gaussian kernel. The time-series
were high-pass filtered (128 s) and a canonical haemody-
namic response function was modelled to the onset of each
event.
Statistical parametric maps were calculated with a
general linear model (Friston et al. 1995). For each subject,
separate first-level models were generated for the placebo
and sulpiride sessions. This first-level analysis included
covariates for neuronal responses elicited during stimulus
presentation, maintenance period, cue (retrieval or manip-
ulation), first motor response, second motor response and
rest. A variable length boxcar was used to model all events
except stimulus presentation, which was a fixed duration,
and the second motor response, which was modelled as a
delta function of zero duration.
Fig. 1 A single trial of the working memory task. Subjects retained
four letters in working memory for a variable maintenance period.
They were then cued to either (a) recall the letters in the same order in
which they were initially presented or (b) reorder the letters into a
prespecified order. After indicating with a button press that they were
ready to respond (response 1), subjects were required to select the
correct sequence from a two-choice array (response 2). Finally,
feedback was given and there was a rest before the next trial began.
In the example trial shown here the subject was cued to reorder the
letters by swapping the locations of the first two letters and the last
two letters (‘pairs’ cue). The subject then correctly selected the
uppermost sequence from the choice array (indicated here by the white
pointer which was not displayed in the actual task) and received
correct feedback
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In order to delineate the network of areas involved in
performance of the task independently of any drug effects,
we computed a contrast, cue minus maintenance period, at
the subject-specific level, separately on scans from the
placebo and sulpiride sessions, and then calculated the
average of the two contrast images from the placebo and
sulpiride sessions. The contrast images from this comparison
were taken to a second-level analysis involving a one-sample
t test in order to test for effects at the group level.
In order to examine whether any regions showed
activation specifically related to manipulation, we computed
a contrast, manipulation cue–simple retrieval cue, at the
subject-specific level, separately on scans from the placebo
and sulpiride sessions, and then calculated the average of the
two contrast images from the placebo and sulpiride sessions.
The contrast images from this comparison were taken to a
second-levelanalysisinvolvinga one-samplet test in order to
test for effects at the group level.
Our prediction that drug effects on process-specific
activity would be restricted to the striatum motivated the
use of striatal and prefrontal regions of interest (ROIs) in
the subsequent analysis of drug effects. The ROIs were
defined from the regions significantly activated in the cue
minus maintenance period group analysis, collapsed across
drug and placebo. This contrast was used for two reasons:
firstly, because it allowed us to investigate drug effects
across the entire network involved in performing the task
rather than just a subset of regions; secondly, because we
observed no significant difference in activation in the
contrast manipulation cue–simple retrieval cue averaged
across the placebo and sulpiride sessions. We took the peak
coordinates of activated clusters from the group analysis
and constructed spheres with 5 mm radiuses centred
on these coordinates. We used spheres, rather than the
clusters themselves, because in some cases the clusters
encompassed several activated regions which we wanted to
examine separately. ROI construction and analysis was
performed using the MarsBar ROI toolbox (Brett et al.
2002). We constructed seven separate ROIs: right and
left putamen; right and left dorsolateral prefrontal cortex
(DLPFC); right and left ventrolateral prefrontal cortex
(VLPFC)/insula and anterior cingulate cortex (ACC). In
order to reduce the chance of making a type 1 error we
divided the p value required for rejection of the null
hypothesis (0.05) by the number of ROIs (seven) to give a
conservative p value of 0.007. For each ROI, a single
BOLD measurement, reflecting the difference in activation
between the manipulation cue and retrieval cue events,
was obtained by running this contrast on each voxel
within the ROI and then averaging across all the resulting
t values.
In order to investigate whether sulpiride modulated task-
related activation, the contrast images from the first-level
contrast cue–maintenance were taken to a second-level
analysis involving a paired-samples t test with drug
(sulpiride or placebo) as the factor. To test our specific
prediction that sulpiride would modulate activation during
the manipulation of information in working memory, we
computed a further contrast, manipulation cue–retrieval
cue, at the subject-specific level, and the contrast images
from this contrast were taken to a second-level analysis
involving a paired-samples t test with drug as the factor.
In order to explore the effects of individual variation in
drug uptake on task-related activation, the contrast images
from the two first-level contrasts were taken to two further
second-level simple regression analyses with sulpiride
plasma levels as the single covariate of interest. The aim
here was to test whether task-related activation was
modulated by sulpiride plasma level and, more specifically,
whether variation in plasma level predicted the difference
between activation associated with the manipulation process
and activation associated with the simple retrieval process.
Results
Drug effects on behavioural performance
To analyse effects of sulpiride on accuracy on the working
memory task, for each subject the proportion of correct
responses in the retrieval and manipulation conditions was
arcsine transformed and subjected to a repeated-measures
ANOVA with drug (placebo and sulpiride) and condition
(retrieval and manipulation) as the factors. There was a
significant main effect of condition, F(1,16)=7.7, p<0.05,
as subjects were more accurate on the retrieval trials than
the manipulation trials. There was no main effect of drug,
F(1,16)=1.4, p=.25, but a significant interaction between
drug and condition, F(1,16)=5.9, p<0.05. The nature of the
interaction was qualified with post-hoc paired t tests
comparing accuracy between the placebo and sulpiride
conditions separately for the same and manipulation
conditions. Accuracy was higher after sulpiride than
after placebo in the manipulation condition, t(16)=−2.4,
p<0.05, but with no difference in the retrieval condition,
t(16)=0.06, p=0.95. Accuracy data are displayed in
Fig. 2.
To analyse effects of sulpiride on the speed of retrieval
and manipulation, RTs to the cue were subjected to a
repeated-measures ANOVAwith drug (placebo and sulpiride)
and condition (retrieval and manipulation) as the factors.
There was a significant main effect of condition, F(1,16)=
117.6, p<0.05, as mean RT was lower in the retrieval
condition (924 ms) than in the manipulation condition
Psychopharmacology (2009) 207:35–45 39(2,098 ms), but no main effect of drug, F(1,16)=0.4, p=0.5,
and no interaction between drug and condition, F(1,16)=0.5,
p=0.5.
fMRI data
Activation related to manipulation/simple retrieval
processes
The results of the contrast cue–maintenance period,
collapsing across the manipulation and simple retrieval
conditions and across placebo and sulpiride sessions,
revealed an extensive network of regions which showed
significantly higher activity during the cue (Fig. 3). These
included bilateral striatum (putamen), bilateral ventrolateral
prefrontal cortex/insula, bilateral dorsolateral prefrontal
cortex, anterior cingulate (ACC), bilateral inferior parietal
lobe, midbrain and occipital cortex.
The contrast manipulation cue–simple retrieval cue,
collapsed across the placebo and sulpiride sessions, did
not reveal any significantly activated clusters.
Drug effects on task-related activation
In the paired-samples t test which examined the overall
effect of sulpiride on task-related activation there was no
significant interaction between drug and the contrast cue–
maintenance in any of the ROIs tested, including L DLPFC:
t(16)=0.4, p=0.35; L putamen: t(16)=1.27, p=0.11;
R putamen: t(16)=1.16, p=0.1; ACC, t(16)=−0.7,
p=0.75; R VLPFC/insula, t(16)=−0.56, p=0.71;
L VLPFC/insula, t(16)=0.48, p=0.32. However the inter-
action approached significance in the R DLPFC, t(16)=2.0,
p=0.03.
In the paired-samples t test which examined the overall
effect of sulpiride on manipulation-specific activation, there
was no significant interaction between drug and the contrast
manipulation cue–retrieval cue in any of the ROIs tested,
including L DLPFC: t(16)=1.14, p=0.14; R DLPFC t(16)=
0.15, p=0.44; L putamen: t(16)=0.66, p=0.26; R putamen:
t(16)=1.0, p=0.17. However, the interaction approached
significance in the ACC, t(16)=1.45, p=0.08, R VLPFC/
insula, t(16)=1.99, p=0.03 and L VLPFC/insula, t(16)=
2.87, p=0.04
Plasma-dependent drug effects on task-related activation
The mean sulpiride plasma level across all subjects,
averaged across the two samples (pre- and post-scanning),
was 567µg/l, and the SD was 295, with a range from 163 to
1,012 µg/l.
There was a significant negative correlation between
plasma level and activation in the contrast manipulation
cue–retrieval cue bilaterally in the putamen: left putamen
Fig. 2 Behavioural performance in the working memory task:
proportion of correct responses in the retrieval and manipulation
conditions after placebo or sulpiride. Error bars are SEM
Fig. 3 Cue-period activity independent of drug effects. Whole-brain
statistical parametric maps (SPM) showing the results of the contrast
cue minus maintenance period, performed at the random-effects level
on the average of the first-level contrast images from the placebo and
sulpiride conditions, superimposed on the Montreal Neurological
Institute (MNI) template brain (p<0.05 corrected for false discovery
rate). Five axial slices are shown from different levels in the vertical
plane. Z coordinates below slices indicate position of the slices in the
vertical plane (far left slice is furthest dorsal, far right slice is furthest
ventral). Task-related activation was found bilaterally in the striatum
(putamen), DLPFC, VLPFC/insula, and ACC, as well as in the
parietal cortex, occipital cortex and midbrain. The labels above the
slices indicate which regions were selected for subsequent ROI
analyses of drug effects
40 Psychopharmacology (2009) 207:35–45(−24, 6, −6), t(16)=3.53, p<0.007; right putamen (24, 10,
−8), t(16)=2.83, p<0.007. As Fig. 4 shows, the difference
in activation between the manipulation and retrieval cues
depended on sulpiride plasma level; subjects with lower
sulpiride plasma levels showed greater activation when
cued to manipulate the items in working memory than
when cued to simply retrieve the items in working memory,
while for subjects with higher plasma levels the pattern
was reversed, with greater activation for the retrieval cue
than for the manipulation cue. There was no significant
correlation between plasma level and activation in this
contrast in any of the other ROIs: L DLPFC t(16)=0.42,
p=0.34; R DLPFC t(16)=0.89, p=0.19; ACC t(16)=
0.49, p=0.31; R VLPFC/insula t(16)=−0.18, p=0.57; L
VLPFC/insula t(16)=2.37, p=0.01.
There was no significant correlation between plasma
level and activation in the contrast cue–maintenance in any
of the ROIs: L DLPFC t(16)=0.25, p=0.40; R DLPFC
t(16)=0.97, p=0.17; L putamen t(16)=2.17, p=0.02;
R putamen t(16)=1.09, p=0.15; ACC t(16)=0.00, p=0.5;
R VLPFC/insula, t(16)=0.89, p=0.19. However the
correlation approached significance in the L VLPFC/insula,
t(16)=2.27, p=0.02.
Drug effects on subjective alertness
In order to investigate the effects of sulpiride on subjective
mood, three factors were calculated from the VAS scores—
alertness, contentment and calmness (see Herbert et al.
1976, for the method of calculating the factors). Paired-
samples t tests carried out on participants’ scores on these
factors revealed no significant differences between the
placebo and sulpiride conditions (p values all >0.3).
Correlations between activation and performance
In order to investigate whether the difference in activation
between the manipulation and retrieval conditions correlat-
ed with manipulation accuracy or RT in the sulpiride
condition, we performed two regression analyses on the
first-level contrast images from the contrast manipulation
cue–retrieval cue, one with manipulation accuracy as the
regressor and one with manipulation (cue) RT as the
regressor. There was no significant correlation with accuracy
either in the left putamen, t(16)=0.57, p=0.29, or in the right
putamen, t(16)=0.41, p=0.34. There was no significant
correlation with RT either in the left putamen, t(16)=0.89,
p=0.19, or in the right putamen, t(16)=1.28, p=0.1.
Correlation between plasma level and accuracy
In order to investigate whether sulpiride plasma levels
predicted performance on the working memory task we
performed bivariate correlations comparing RT and accuracy
on the task with plasma levels. There was no significant
correlation between plasma and accuracy either in the simple
retrieval condition, r=0.43, p=0.08 or in the manipulation
condition, r=−0.04, p=0.88, and there was no significant
correlation between plasma level and RT either in the simple
retrieval condition, r=−0.02, p=0.95, or in the manipulation
condition, r=−0.01, p=0.98.
Discussion
We examined the effects of the DA D2 receptor antagonist
sulpiride on brain activation during performance of a verbal
working memory task requiring different levels of manip-
ulation. We observed no overall effect of sulpiride on task-
related activation. However, as predicted, we observed a
plasma-level-dependent effect of sulpiride on activation in
the putamen associated with the manipulation of informa-
tion in working memory. Lower sulpiride plasma levels
were associated with greater activation in manipulation
trials than in simple retrieval trials, whilst higher sulpiride
plasma levels were associated with the opposite pattern-
greater activation in simple retrieval trials than in manip-
ulation trials. The results establish a key link between DA
receptor antagonism and a striatally based system for
manipulating information in working memory. They
also highlight the importance of taking into account drug
plasma levels in the analysis of pharmacological functional
neuroimaging data.
Fig. 4 Scatterplot showing the negative correlation between sulpiride
plasma levels and difference in activation between manipulation and
simple retrieval trials in the left putamen. Lower sulpiride plasma
levels are associated with positive t values (manipulation > retrieval),
whilst higher sulpiride plasma levels are associated with negative t
values (manipulation < retrieval). Individual subjects’ plasma values
were calculated from the mean of the pre- and post- scanning values.
Individual subjects’ t values reflect the effect size of the contrast
manipulation cue–retrieval cue and were extracted by performing this
contrast at the single-subject level on the 5 mm sphere ROI centred on
the left putamen, MNI coordinates (−24, 6, −6)
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antagonist, modulated striatal activation during working
memory manipulation is consistent with previous studies
suggesting a link between DA D2 receptor signalling and
the process of updating task-related working memory
representations. For example, Mehta et al. (2004) found
that sulpiride impaired task-set switching and attentional set
shifting, tasks in which subjects are required to repeatedly
update goal-related representations. Frank and O’Reilly
(2006) found that cabergoline and haloperidol, both
selective D2 agents, modulated the efficacy of working
memory updating. Cools et al (2007) found that bromo-
criptine, a D2 receptor agonist, improved the flexible
updating of working memory representations in trait
impulsive subjects, and that these improvements were
associated with modulations of striatal, but not prefrontal,
activation. The present results support and extend these
findings by showing that a selective DA D2/D3 receptor
antagonist selectively modulated manipulation-related
activation in a dose-dependent fashion.
The present data are also consistent with findings from
PD, in which patients with a progressive loss of DA
neurons from the striatum are impaired on tasks requiring
the flexible updating of task-related representations (Owen
et al. 1992, 1993; Cools et al. 2001a, b; Lewis et al. 2003).
A recent PET study has provided strong evidence that these
functional impairments are caused by striatal DA depletion
(Sawamoto et al. 2008). Our results are consistent with this
hypothesis, providing converging evidence for a link
between striatal DA and flexible behaviour, and further
suggest that the gradual loss of cognitive flexibility in PD
may be due specifically to a loss of DA D2 receptors in the
striatum.
It is well established that DA D1 signalling in the PFC
plays an important role in maintaining stable working
memory representations. However, several authors have
hypothesised that DA plays a different role at the level of
the striatum, facilitating the flexible updating of task-
relevant information in working memory (Frank et al.
2001; Durstewitz and Seamans 2002; Bilder et al. 2004).
The present data are consistent with this hypothesis. In
simple retrieval trials, performance is dependent on retrieving
the representation of the letter-string held in working memory
during the delay period. In contrast, in manipulation trials
subjects must rapidly reorder the letter-string according to the
cue, a process requiring the selective updating of the contents
of working memory. The modulation of manipulation-related
activation by sulpiride suggests that this striatal ‘gating’
mechanism is specifically dependent on D2 receptor signal-
ling. This is consistent with findings in rats that manipulation
of tonic DA release selectively modulates PFC function
through altered stimulation of D2 receptors (Goto and Grace
2005), and provides a potential mechanism of action for the
therapeutic effects of antipsychotics such as sulpiride in
schizophrenia.
A previous neuroimaging study of sulpiride found mixed
results with respect to drug modulations of process-specific
activity. Mehta et al. (2003) used PET to investigate the
effects of sulpiride 400 mg on striatal rCBF during spatial
working memory and planning. They found no effect of
sulpiride on rCBF related specifically to working memory
but some evidence that sulpiride attenuated rCBF in the
caudate nucleus during planning and that the drug-related
attenuation was associated with changes in performance. The
lackofeffectofsulpirideonworkingmemory-relatedrCBFin
that study may be due to differences in the sensitivity of
different tasks to DA manipulations. However, it is also
possible that the inability to separate out neural activation
associated with specific cognitive processes using PET
scanning caused more subtle modulations of process-specific
activation to be masked.
It should be noted that the putamen region in which
manipulation-specific activation correlated with sulpiride
plasma levels did not show any selective task-related (i.e.
independent of any drug effect) activation in the contrast of
manipulation–retrieval cue periods. However, the putamen
was activated more generally during the manipulation and
retrieval cues when compared with the maintenance period.
Thus, activation in the putamen appears to be sensitive to
differences in task requirements in terms of the level of
manipulation of information required, but only under
conditions of partially blocked dopamine D2 receptor
activity after sulpiride.
One possible explanation for this pattern of results is that
putamen activation is, under normal conditions, relatively
robust to changes in working memory manipulation
demands, due to a high signal-to-noise ratio. However, a
reduction in D2 receptor activity introduces noise into the
system, rendering putamen activation more vulnerable to
changes in working memory processing demands, and
leading to differences in activation between the manipu-
lation and retrieval cue conditions.
The present data highlight the importance of taking into
account drug plasma levels in the analysis of pharmaco-
logical functional neuroimaging data, and in this respect
complement previous findings of plasma-dependent effects
of dopaminergic agents on task-related brain activation
(Muller et al. 2005). Four hundred milligrams of sulpiride
has been shown to lead to only 28% occupancy of DA D2
receptors in the striatum (Mehta et al. 2008) and 35–60% in
extrastriatal regions (Takano et al. 2006); extrastriatal D2
receptor occupancy after sulpiride is dose- and plasma-
level-dependent. Thus, variation in plasma levels will likely
lead to difficulties detecting small overall differences in
activation between conditions. Furthermore, plasma levels
may vary according to many incidental and uncontrollable
42 Psychopharmacology (2009) 207:35–45factors, including: individual differences in drug pharma-
cokinetics (rate of absorption, time of peak plasma
concentration); food intake prior to testing (despite attempts
to control for this factor, subjects may not follow
instructions); variation in the time between dosing and first
blood sample; and variation in scanning time (despite
attempts to keep these final two factors consistent,
unavoidable events can lead to small differences between
subjects). Despite the lack of an overall drug effect, our
data show that careful measurement of plasma levels can
strengthen a study by providing a clear dose–response
relationship, which, in human pharmacological studies is
often difficult to achieve due to ethical and financial
constraints.
It should be noted that one limitation in interpretation of
the present findings is that sulpiride, in common with
virtually all ‘selective‘ D2 receptor antagonists and ago-
nists, exhibits affinity for the D3 as well as the D2 receptor
(Levant 1997). Although DA D3 receptors appear to be
preferentially located to the ventral rather than the dorsal
striatum, there is evidence of some expression of D3
receptors in the putamen (Schwartz et al 2000) and so it
cannot be excluded that some of the effects of sulpiride
described here are due its antagonism of that receptor.
Alongside the neural effects of sulpiride, we observed a
drug-induced improvement in accuracy in the manipulation
condition but not in the retrieval condition, suggesting a
selective effect of drug on the process of manipulation. It
should be noted that accuracy in the retrieval condition
was already high after placebo, and may therefore have
been insensitive to pharmacological manipulation. It is
nevertheless interesting that sulpiride led to an improvement
rather than a reduction in accuracy in the manipulation
condition.
This behavioural improvement is not without precedent.
In humans, studies involving DA D2 antagonists such as
sulpiride and haloperidol have shown that these drugs can
lead to enhanced performance on certain working memory
and executive tasks, especially those with a strategic
(Mehta et al. 2003; Mehta et al. 2004) or incentive learning
(Frank and O’Reilly 2006) component. These results are
reminiscent of findings that the dopamine precursor L-dopa
and dopamine agonists such as bromocriptine can paradox-
ically lead to impairments on certain tasks such as reversal
learning while leading to improvements on other tasks such
as spatial memory in healthy volunteers (Mehta et al. 2001)
and task-switching in PD (Cools et al. 2001a, b, 2003).
These data have been interpreted as reflecting an ‘over-
dosing’ of the DA system, whereby an increase in DA can
lead to impairments on tasks that require lower levels of
DA for optimal performance whilst leading to improve-
ments on tasks that require higher levels of DA for optimal
performance (Cools and Robbins 2004). In a similar
fashion, the present increase in accuracy in the manipu-
lation condition may be due to the fact that sulpiride
reduces DA signalling to the optimal level required for
performance of the present manipulation task.
An alternative explanation for the improvement in
behavioural performance after sulpiride is that it is actually
due to a drug-induced increase in extracellular DA. Animal
studies have shown that relatively low single doses of DA
antagonists such as sulpiride and haloperidol increase levels
of striatal DA (Imperato and Di Chiara 1985; Moghaddam
and Bunney 1990; Kawagoe et al. 1992) by inhibiting the
presynaptic activity of DA autoreceptors (Garris et al.
2003). This increased DA will hit D1 receptors and thus
behavioural improvements after sulpiride may in fact be
attributable to the increase in extracellular striatal DA
induced by downregulation of presynaptic activity. Indeed,
Frank and O’Reilly (2006) interpret their finding that
haloperidol enhanced incentive learning in this context,
and further hypothesise that previous findings of sulpiride-
induced impairments on attentional switching may also be
due to an increase in DA causing excessive attention to be
paid to the previously irrelevant dimension. This interpre-
tation is also consistent with findings that sulpiride
increases connectivity between the ventral midbrain and
striatum and between the striatum and thalamus (Honey et
al. 2003). Thus, the present sulpiride-induced improvement
in accuracy during the manipulation of information in
working memory may be due to an increase in extracellular
striatal DA leading to enhanced attention to task-relevant
information.
A final possible explanation for the improvement in
accuracy is that striatal activation is actually detrimental to
the process of manipulating information in working
memory. Previous studies have associated striatal activation
with the learning of simple stimulus–response mappings
(Graybiel 2008). If this is the case, then simple retrieval and
more complex manipulation processes may act mutually
antagonistically, such that improvement in one process
leads to impairment in the other. In the present example,
sulpiride may reduce the ability to respond via a simple S-R
strategy and consequently improve the ability to adopt a
more flexible approach to the working memory task. This
explanation, whilst speculative, has the advantage of link-
ing the drug effects on striatal activation with the observed
behavioural effects.
In summary, we observed a dose-dependent effect of
sulpiride on manipulation-related activation bilaterally in
the striatum in the context of an improvement in accuracy
on manipulation trials. The results are consistent with
the hypothesis that DA D2 receptor signalling in the
striatum performs a gating function, enabling or prevent-
ing the updating of currently relevant working memory
representations.
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